Atomoxetine for Hyperactivity in Autism Spectrum Disorders: Placebo-Controlled Crossover Pilot Trial

To explore placebo-controlled efficacy and safety of atomoxetine (ATX) for attention-deficit/hyperactivity disorder (ADHD) symptoms in children with autism spectrum disorders (ASD). Children ages 5 to 15 with ASD and prominent ADHD symptoms were randomly assigned to order in a crossover of clinicall...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American Academy of Child and Adolescent Psychiatry 2006-10, Vol.45 (10), p.1196-1205
Hauptverfasser:	ARNOLD, L. EUGENE, AMAN, MICHAEL G., COOK, AMELIA M., WITWER, ANDREA N., HALL, KRISTY L., THOMPSON, SUSAN, RAMADAN, YASER
Format:	Artikel
Sprache:	eng
Schlagworte:	Aberrant Behavior Checklist Adolescent Adolescents Adrenergic Uptake Inhibitors - therapeutic use Atomoxetine Atomoxetine Hydrochloride Attention Deficit Disorder with Hyperactivity - drug therapy Attention Deficit Disorder with Hyperactivity - epidemiology Attention Deficit Disorders Attention deficit disorders. Hyperactivity Attention deficit hyperactivity disorder Autism Autism Spectrum Disorders Autistic Disorder - epidemiology Autistic spectrum disorders Behavior Problems Biological and medical sciences Child Child clinical studies Children clinical trial Clinical trials Comparative Analysis Cross-Over Studies Developmental disorders Double-Blind Method Drug Therapy Female Humans Hyperactivity Infantile autism Male Medical sciences Outcomes of Treatment Pervasive Developmental Disorders Pharmacology Pilot Projects Propylamines - therapeutic use Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychotropic drugs Symptoms (Individual Disorders) T Test Treatment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!